Cart
sales@molnova.com
34-Dihydroxyflavone
CAS No. 4143-64-0
34-Dihydroxyflavone( —— )
Catalog No. M21261 CAS No. 4143-64-0
34-Dihydroxyflavone Acts as an Antioxidant and Antiapoptotic Agent .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 10MG | 33 | In Stock |
|
| 25MG | 50 | In Stock |
|
| 50MG | 70 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name34-Dihydroxyflavone
-
NoteResearch use only, not for human use.
-
Brief Description34-Dihydroxyflavone Acts as an Antioxidant and Antiapoptotic Agent .
-
Description34-Dihydroxyflavone Acts as an Antioxidant and Antiapoptotic Agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4143-64-0
-
Formula Weight254.24
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (491.66 mM)
-
SMILESOc(ccc(C(Oc1c2cccc1)=CC2=O)c1)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee K S Kim E Y Jeon K et al. 34-Dihydroxyflavone Acts as an Antioxidant and Antiapoptotic Agent to Support Bovine Embryo Development In Vitro[J]. Journal of Reproduction & Development 2011 57(1):127-134.
molnova catalog
related products
-
Buquinolate
Buquinolate is an anticoccidial agent used in poultry, and the medicated chickens can produce higher levels of egg production and gain weight. Buquinolate does not interfere with the formation of immunity against coccidia.
-
Peptide C105Y
C105Y, a synthetic peptide (CSIPPEVKFNKPFVYLI) based on the amino acid sequence corresponding to residues 359-374 of alpha1-antitrypsin, enhances gene expression from DNA nanoparticles.
-
RFRP-2 (rat)
RFRP-3 (rat) is a neuropeptide. RFRP-3 (rat) inhibits gonadotropin secretion, causing a marked increase in ghrelin mRNA and plasma growth hormone levels.
